The largest database of trusted experimental protocols

Nanospect ct scanner

Manufactured by Mediso
Sourced in Hungary

The NanoSPECT/CT scanner is a multi-modal imaging system that combines single-photon emission computed tomography (SPECT) and computed tomography (CT) technologies. The system is designed to acquire high-resolution, small-animal images for preclinical research applications.

Automatically generated - may contain errors

7 protocols using nanospect ct scanner

1

In Vivo SPECT/CT Imaging of Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total 4 mice were scanned as exemplary cases for in vivo SPECT/CT imaging. Under isoflurane anesthesia (1%–2% isoflurane in 2:1 O2:N2O volume ratio) tracer injection and whole-body imaging was performed 2 h and 4 h after injection with a 4-head NanoSPECT/CT scanner (Mediso Ltd.). SPECT scans were acquired using a multipinhole collimator set (SCIVIS), each collimator with 9 pinholes (1.4-mm pinhole diameters). SPECT imaging was performed with an energy window of 140 keV ± 5% and an acquisition time of 60 min. Images were reconstructed with isotropic voxel output sizes of 300–448 µm, depending on count rates (HiSPECT; SCIVIS). CT scans were acquired at 98 µm detector resolution and reconstructed at isotropic voxel sizes of 200 µm (InVivoScope 1.43; Bioscan). Further on, six non-tumor bearing mice were scanned to qualitatively evaluate the thyroid uptake of tracers.
+ Open protocol
+ Expand
2

Multi-Modal Imaging of Mice In Vivo

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anaesthetised and whole-body SPECT/CT scans were acquired using a NanoSPECT/CT scanner (Mediso, Hungary). CT images were acquired using a 45 kilo volt peak (kVp) X-ray source, 500 ms exposure time in 180 projections, a pitch of 1.5 with an acquisition time of 7 minutes. SPECT images were obtained with a 4-head scanner with nine 1.4 mm pinhole apertures in helical scan mode using a time per view of 60–90 seconds resulting in a scan time of 36–60 minutes and respiration was monitored throughout the scan and body temperature maintained with a warm air blower. CT images were reconstructed in voxel size 124 × 124 × 124 μm using Bioscan InVivoScope (Bioscan, USA) software, whereas SPECT images were reconstructed in a 256 × 256 matrix using HiSPECT (ScivisGmbH, Bioscan). Images were fused and analysed using InVivoScope (Version 1.44, Bioscan). 3D ROIs were created for brain, lungs, liver and kidney for each time point using VivoQuant (inviCRO version 2.5 patch 1) software. After correcting for 111In decay, the 3D ROIs were calculated as the percentage of injected dose per mm3 (%ID mm–3). Representative maximum intensity projection (MIP) images were presented using %ID mm–3 as color scale after decay correction and Guassian filtering of 0.8 by utilising the same software.
+ Open protocol
+ Expand
3

Small Animal CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were scanned under isoflurane anesthesia (1.0–1.5 % in 2:1 O2:N2O volume ratio) with the CT functionality of a NanoSPECT/CT scanner (Mediso Ltd., Budapest, Hungary). CT scans were made at 45 kVp, 1.77 μA, with 180 projections, 500 ms per projection and 96 μm pixel size. Images were reconstructed with the InVivoScope (vs.1.43) at isotropic voxel sizes of 100 μm and analyzed with the DICOM viewers Osirix (Pixmeo SARL, Bernex, Switzerland, v.5.1.7 64-bit) and the open source program AMIDE: A Medical Imaging Data Examiner (amide.exe 1.0.4, ©Andreas Loening, http://amide.sourceforge.net/; GNU GPL).
+ Open protocol
+ Expand
4

Quantitative SPECT Imaging of [177Lu]Lu-DOTA-TATE Biodistribution

Check if the same lab product or an alternative is used in the 5 most similar protocols
For initiation of peptide receptor radionuclide therapy (PRRT), each animal received a single intravenous injection of 70 MBq [177Lu]Lu-DOTA-TATE (pharmaceutically equivalent to 1.2 nmol) delivered in 0.2 mL of 0.154 mol/L NaCl(aq) through a tail vein catheter. Small animal single-photon emission computed tomography (SPECT) was initiated 22‒26 hours after radiotracer injection using the nanoSPECT/CT scanner (Mediso Medical Imaging Systems). With each SPECT scan, a corresponding CT image was recorded and used for anatomical referencing and attenuation correction. Images were post-processed and analyzed using ROVER (ABX) and displayed as maximum intensity projections at indicated scaling. Activity concentration in tissues was determined and reported as AV mean (VOI-averaged volume activity AV tissue 24h, MBq/mL). Details on quantitative SPECT image analysis are provided in Supplemental Information 1.5.
+ Open protocol
+ Expand
5

Radiolabeled Compound Biodistribution in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were injected via a lateral tail vein with 111 In-labeled 3BP-227 (21-47 MBq; n 5 6), 3BP-228 (33-44 MBq; n 5 4), or 3BP-483 (31-44 MBq; n 5 3) under isoflurane anesthesia (1%-2% isoflurane in 2:1 O 2 : N 2 O volume ratio). Whole-body imaging was performed 3, 6, 12, and 24 h after injection with a 4-head NanoSPECT/CT scanner (Mediso Ltd.). SPECT scans were acquired using a multipinhole collimator set (SCIVIS), each collimator with 9 pinholes (1.4-mm pinhole diameters). SPECT imaging was performed with 2 energy windows of 171 keV 6 5% and 245 keV 6 5% and an acquisition time of 60 min. Images were reconstructed with isotropic voxel output sizes of 300-600 mm, depending on counting rates (HiSPECT; SCIVIS). CT scans were acquired at a 192-mm isotropic detector resolution and reconstructed at isotropic voxel sizes of 200 mm (InVivoScope 1.43; Bioscan). After the last acquisition, mice were sacrificed and included into the 24-h-after-injection cohort for the ex vivo biodistribution studies described below.
+ Open protocol
+ Expand
6

Quantitative PET/SPECT Imaging of γδ-T Cells and PLAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
89Zr-radiolabeled γδ-T cells (107 cells/animal in 100 μL, 0.3−3 MBq 89Zr, single γδ-T donor per experiment) were injected i.v. at t = 0 hr and imaged by PET/CT within 30 min. PET/CT imaging was performed for 30−240 min (as indicated) on a nanoScan PET-CT scanner (Mediso). For tumor imaging, 100 μL 99mTcO4 (15−25 MBq) in saline was injected i.v., and SPECT-CT was performed 40 min thereafter in a NanoSPECT/CT scanner (Mediso; 1-mm collimators, 30-min scan). PET-CT and SPECT-CT were repeated at t = 48 and 168 hr. For PLA imaging by SPECT-CT, PLA was radiolabeled with [111In]In(oxinate)3 and administered i.v. (7 MBq 111In/mouse) to NSG mice. PET- and SPECT-CT datasets were reconstructed using a Monte Carlo-based full-3D iterative algorithm (Tera-Tomo, Mediso). Images were co-registered and analyzed using VivoQuant v.2.50 (Invicro). Regions of interest (ROIs) were delineated for PET activity quantification in specific organs. Uptake in each ROI was expressed as a percentage of injected dose per volume (% ID/mL).
+ Open protocol
+ Expand
7

Theranostic Monitoring of Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
On day 0, MDA-MB-231 cells expressing human sodium-iodide symporter (hNIS)53 were implanted in the mammary fat pad of female SCID/beige mice (6-8 weeks, Charles River, UK), between the 4th and 5th nipple. On day 14, 111In-PLA (6-8 MBq 111In, 5 mg/kg alendronate and 4 μmol lipids/mouse) were injected via the tail vein. On day 16 and day 21, the mice were scanned in a NanoSPECT/CT scanner (Mediso, Hungary; 1 mm collimators, 30 min scan). Data sets were reconstructed using a Monte-Carlo-based full-3D iterative algorithm (Tera-Tomo, Mediso). Images were co-registered and analyzed using VivoQuant v2.50 (Invicro).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!